A223250 logo

DreamCIS, Inc. Stock Price

KOSDAQ:A223250 Community·₩80.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A223250 Share Price Performance

₩3,265.00
-55.00 (-1.66%)
₩3,265.00
-55.00 (-1.66%)
Price ₩3,265.00

A223250 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with excellent balance sheet.

3 Risks
2 Rewards

DreamCIS, Inc. Key Details

₩73.3b

Revenue

₩53.8b

Cost of Revenue

₩19.5b

Gross Profit

₩19.1b

Other Expenses

₩328.8m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
13.37
26.56%
0.45%
17.8%
View Full Analysis

About A223250

Founded
2000
Employees
391
CEO
JeongHee Yoo
WebsiteView website
www.dreamcis.com

DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada. It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.

Recent A223250 News & Updates

Recent updates

No updates